Is CD133 Expression a Prognostic Biomarker of Non-Small-Cell Lung Cancer? A Systematic Review and Meta-Analysis

BACKGROUND: The clinical and prognostic significance of CD133 in non-small-cell lung cancer (NSCLC) remains controversial. To clarify a precise determinant of the clinical significance of CD133, we conducted a systematic review and meta-analysis to evaluate the association of CD133 with prognosis an...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Hong, Qi, Xiao-wei, Yan, Guang-ning, Zhang, Qing-bi, Xu, Chuan, Bian, Xiu-wu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4062503/
https://www.ncbi.nlm.nih.gov/pubmed/24940615
http://dx.doi.org/10.1371/journal.pone.0100168

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4062503/
https://www.ncbi.nlm.nih.gov/pubmed/24940615
http://dx.doi.org/10.1371/journal.pone.0100168

Ejemplares similares